Transaction #14351 · Form 4 · 0001193125-25-305257
Inogen Inc · Exercise / conversion · Restricted Stock Unit
Inogen Inc · Transacted December 1, 2025 · Filed December 2, 2025
What does this filing report?
An SEC Form 4 filing for Inogen Inc records an exercise / conversion involving Restricted Stock Unit on December 1, 2025. The reported quantity was 31,566. The filing date is December 2, 2025. This is one transaction record; amounts are not allocated among any joint reporting owners.
The acquisition category describes how securities were received. It does not by itself establish a cash purchase of common stock. Read the transaction code definitionsand the original filing before interpreting the amounts.
Transaction details
- Company
- Inogen Inc
- Company CIK
- 0001294133
- Security type
- Derivative
- Acquisition type
- Exercise / conversion · Code M
- Quantity acquired
- 31,566
- Reported price
- 0
- Reference value
- 0
- Currency
- Currency not specified
- Ownership
- Direct
- Holdings after transaction
- 31,565
- Ownership description
- Not reported
- SEC acceptance time
- Dec 2, 2025, 4:08 PM EST
- 10b5-1 indication
- Not indicated
Reference value is reported quantity × reported price. It is not a confirmed cash payment or an estimate of a derivative's economic value. A missing currency is not assumed to be USD.
Reporting owners
- Ramade Gregoire ↗
Chief Commercial Officer
CIK 0001752887
These are the reporting owners named in the filing. Quantities and amounts are not allocated among co-reporters. Roles reflect this filing, not a current profile.
Company listings
This transaction is not mapped to a specific company listing.
Derivative terms
- Underlying security
- Common Stock
- Underlying quantity
- 31,566
- Conversion / exercise price
- Not reported
- Exercise date
- Not reported
- Expiration date
- Not reported
Filing footnotes & remarks
- F1
- The reported shares were withheld to cover the Reporting Person's tax withholding liability in connection with a portion of a time-based restricted stock award that vested on December 1, 2025.
- F2
- Each restricted stock unit represents a contingent right to receive one share of Inogen common stock.
- F3
- Subject to the reporting person's continued service, 1/3rd of the restricted stock units shall vest one year from December 1, 2023 (the "Vesting Commencement Date"), and 1/3rd of the restricted stock units shall vest every year thereafter on the same day of the year as the Vesting Commencement Date.
Footnotes are reproduced as plain text from the current source filing. For the full context, read the original SEC filing.
This record was updated Eastern Time. This is the stored record update time, not the transaction date. Report a correction.